Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo study for healthy aging
García-García, F. J.
Tresguerres, J. A. F.
Gutiérrez Avila, G.
AffiliationHospital Universitario de Getafe, Toledo
MetadataShow full item record
AbstractAdverse effects of higher endogenous estradiol (E2) levels on various clinical outcomes and on determinants of the frailty syndrome have recently been reported. However, there are no data about the potential relationship between E2 and frailty. We aimed to study the association between E2 levels and frailty among older postmenopausal women not taking hormonal therapy.
CitationCarcaillon, L. et al (2012) 'Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the toledo study for healthy aging' J. Clin. Endocrinol. Metab. 97 (8):2898-906
- Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging.
- Authors: Carcaillon L, Blanco C, Alonso-Bouzón C, Alfaro-Acha A, Garcia-García FJ, Rodriguez-Mañas L
- Issue date: 2012
- Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men.
- Authors: Nakhai Pour HR, Grobbee DE, Muller M, van der Schouw YT
- Issue date: 2007 Mar
- High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.
- Authors: Carcaillon L, Brailly-Tabard S, Ancelin ML, Rouaud O, Dartigues JF, Guiochon-Mantel A, Scarabin PY
- Issue date: 2014 Feb 11
- Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
- Authors: Rachoń D, Suchecka-Rachoń K, Hak Ł, Myśliwska J
- Issue date: 2006 Sep-Oct
- Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women.
- Authors: Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, Kooperberg CL, Woods NF, LaCroix AZ
- Issue date: 2009 Oct